Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells E Ooko, MEM Saeed, O Kadioglu, S Sarvi, M Colak, K Elmasaoudi, ... Phytomedicine 22 (11), 1045-1054, 2015 | 365 | 2015 |
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning O Kadioglu, M Saeed, HJ Greten, T Efferth Computers in biology and medicine 133, 104359, 2021 | 195 | 2021 |
Collateral sensitivity of natural products in drug-resistant cancer cells T Efferth, MEM Saeed, O Kadioglu, EJ Seo, S Shirooie, AT Mbaveng, ... Biotechnology advances 38, 107342, 2020 | 134 | 2020 |
Kaempferol is an anti-inflammatory compound with activity towards NF-κB pathway proteins O Kadioglu, J Nass, MEM Saeed, B Schuler, T Efferth Anticancer research 35 (5), 2645-2650, 2015 | 125 | 2015 |
Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking M Saeed, O Kadioglu, H Khalid, Y Sugimoto, T Efferth The Journal of nutritional biochemistry 26 (1), 44-56, 2015 | 109 | 2015 |
Evaluating ancient Egyptian prescriptions today: anti-inflammatory activity of Ziziphus spina-christi O Kadioglu, S Jacob, S Bohnert, J Naß, MEM Saeed, H Khalid, I Merfort, ... Phytomedicine 23 (3), 293-306, 2016 | 94 | 2016 |
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein—a well-known, yet poorly understood drug transporter M Zeino, MEM Saeed, O Kadioglu, T Efferth Investigational new drugs 32, 618-625, 2014 | 76 | 2014 |
Biopiracy of natural products and good bioprospecting practice T Efferth, M Banerjee, NW Paul, S Abdelfatah, J Arend, G Elhassan, ... Phytomedicine 23 (2), 166-173, 2016 | 73 | 2016 |
Synergy and antagonism of active constituents of ADAPT-232 on transcriptional level of metabolic regulation of isolated neuroglial cells A Panossian, R Hamm, O Kadioglu, G Wikman, T Efferth Frontiers in neuroscience 7, 16, 2013 | 73 | 2013 |
Pharmacogenomics of cantharidin in tumor cells O Kadioglu, NS Kermani, G Kelter, U Schumacher, HH Fiebig, HJ Greten, ... Biochemical pharmacology 87 (3), 399-409, 2014 | 64 | 2014 |
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin—Two Main Metabolites of Curcuma longa—in … E Ooko, O Kadioglu, HJ Greten, T Efferth Frontiers in pharmacology 8, 38, 2017 | 60 | 2017 |
The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65 C Hutterer, I Niemann, J Milbradt, T Fröhlich, C Reiter, O Kadioglu, ... Antiviral research 124, 101-109, 2015 | 55 | 2015 |
Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades T Efferth, O Kadioglu, MEM Saeed, EJ Seo, AT Mbaveng, V Kuete Phytochemistry Reviews 20, 7-53, 2021 | 52 | 2021 |
Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes KKW To, X Wu, C Yin, S Chai, S Yao, O Kadioglu, T Efferth, Y Ye, G Lin Journal of ethnopharmacology 203, 110-119, 2017 | 52 | 2017 |
Mode of Action Analyses of Neferine, a Bisbenzylisoquinoline Alkaloid of Lotus (Nelumbo nucifera) against Multidrug-Resistant Tumor Cells O Kadioglu, BYK Law, SWF Mok, SW Xu, T Efferth, VKW Wong Frontiers in pharmacology 8, 238, 2017 | 51 | 2017 |
Pharmacogenomics of scopoletin in tumor cells EJ Seo, M Saeed, BYK Law, AG Wu, O Kadioglu, HJ Greten, T Efferth Molecules 21 (4), 496, 2016 | 51 | 2016 |
Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses O Kadioglu, MEM Saeed, M Valoti, M Frosini, G Sgaragli, T Efferth Biochemical pharmacology 104, 42-51, 2016 | 51 | 2016 |
A five-year survey of cancer prevalence in Sudan MEM Saeed, J Cao, B Fadul, O Kadioglu, HE Khalid, Z Yassin, ... Anticancer research 36 (1), 279-286, 2016 | 51 | 2016 |
Effect of ABC transporter expression and mutational status on survival rates of cancer patients O Kadioglu, MEM Saeed, M Munder, A Spuller, HJ Greten, T Efferth Biomedicine & Pharmacotherapy 131, 110718, 2020 | 50 | 2020 |
Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells S Abdelfatah, M Böckers, M Asensio, O Kadioglu, A Klinger, E Fleischer, ... Phytomedicine 86, 153196, 2021 | 49 | 2021 |